I think this is very interesting, more effective and taken orally.
Not sure if this topic has been previously posted:
I think this is very interesting, more effective and taken orally.
Not sure if this topic has been previously posted:
Very interesting and will soon start Phase II clinicals. Thanks for posting.
This is the article they mentioned:
ascopubs.org/doi/abs/10.120...
The clinical trial is already recruiting patients:
This looked like a very good trial until I read the exclusion criteria. After 23 years of treatment with a total of about 3 years of HT I have the beginning of t-NEPC (treatment induced neuroendocrine prostate cancer). Exclusion criteria rules out anyone with NEPC.
Talk about disappoinment!